ILE

Isolagen (ILE)

Isolagen

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:ILE

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2009/10/06	22 : 00	PR Newswire (US)	Isolagen, Inc. Reorganizes as Fibrocell Science, Inc.	AMEX:ILE
2009/06/17	06 : 52	PR Newswire (US)	Isolagen, Inc. Announces Filing of Voluntary Petition Under Chapter 11 of the Bankruptcy Code	AMEX:ILE
2009/05/08	22 : 00	PR Newswire (US)	Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review	AMEX:ILE
2009/05/07	04 : 18	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILE	Isolagen
2009/05/07	04 : 14	PR Newswire (US)	Isolagen Receives Bridge Financing to Allow it to Seek Debtor-in-Possession Financing in Connection With a Possible Filing Under	AMEX:ILE
2009/05/06	07 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/05/01	06 : 16	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	AMEX:ILE	Isolagen
2009/04/30	06 : 51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/04/22	08 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/04/15	22 : 38	Edgar (US Regulatory)	Annual Report (10-K)	AMEX:ILE	Isolagen
2009/04/10	06 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/04/07	05 : 51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/04/01	08 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/04/01	06 : 15	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	AMEX:ILE	Isolagen
2009/03/31	08 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/03/24	06 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/03/21	06 : 06	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILE	Isolagen
2009/03/21	06 : 00	PR Newswire (US)	Isolagen, Inc. Receives Notification Letter from Amex	AMEX:ILE	Isolagen
2009/03/19	07 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/03/12	07 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/03/09	22 : 00	PR Newswire (US)	Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration	AMEX:ILE	Isolagen
2009/03/07	07 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ILE	Isolagen
2009/03/05	23 : 25	PR Newswire (US)	Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acn	AMEX:ILE	Isolagen
2009/02/18	03 : 47	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	AMEX:ILE	Isolagen
2009/02/18	03 : 36	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	AMEX:ILE	Isolagen
2009/02/18	00 : 28	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	AMEX:ILE	Isolagen
2009/02/04	23 : 20	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILE	Isolagen
2008/12/04	07 : 02	Edgar (US Regulatory)	Current report filing (8-K)	AMEX:ILE	Isolagen
2008/11/07	07 : 27	Edgar (US Regulatory)	Quarterly Report (10-Q)	AMEX:ILE	Isolagen
2008/10/23	10 : 58	PR Newswire (US)	Isolagen, Inc. Provides Analysis of Data from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles	AMEX:ILE	Isolagen